Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megestrol Acetate + Letrozole in ER+ Breast Cancer
NCT03306472Phase 2Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Jul 2017
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of megestrol in breast cancer, sponsored by Cambridge University Hospitals NHS Foundation Trust. Started Jul 2017; status: completed.
02
Drugs
megestrol
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03306472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03306472.